Bluejay Diagnostics Inc Sustainability Reports
Bluejay Diagnostics, Inc. develops rapid, near-patient medical diagnostic testing solutions for critical care applications. Its primary product platform is the Symphony System, which focuses on triage and monitoring for conditions such as sepsis.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
2 reports from 2022 to 2023
Company Profile
Bluejay Diagnostics, Inc. develops rapid, near-patient medical diagnostic testing solutions for critical care applications. Its primary product platform is the Symphony System, which focuses on triage and monitoring for conditions such as sepsis.
Reports
2 total
Limited sustainability disclosure available
This company only publishes Annual Reports without dedicated sustainability sections.
